Jacques Normand, Ph.D. Director, AIDS Research Program National Institute on Drug Abuse NIDA’s New HIV/AIDS Research Program.

Slides:

Advertisements

Similar presentations

Research Training Programs at the NIH Marya Levintova, Ph.D. International Program Officer for Russia, Eurasia and Arctic Affairs Division of International.

Advertisements

UCSC History. UCSC: A brief history 60s University Placement Committee A lot of field trips/interaction with employers.

TM NCI’s Smoking Cessation Activities and Priorities: Discovery, Development and Delivery Scott J. Leischow, Ph.D. National Cancer Institute.

Role of the HIV/AIDS community in science & regulatory advocacy Nikos Dedes European AIDS Treatment Group 22 July 2014, Melbourne.

What’s NIH? National Cancer Institute National Eye Institute National Heart, Lung, and Blood Inst. National Human Genome Research Inst National Institute.

NIH Academic Research Enhancement Award (AREA) R15 AASCU November 5, 2009 Mary Ann Guadagno, PhD Office of Extramural Research National Institutes of Health.

Promoting Diversity and Science for Health Equity -- Introduction of NIDA Minority Diversity Programs Yu (Woody) Lin, M.D., Ph.D Program Director Division.

Institute for Health and Society Institute for Health and Society Improving Health and Advancing Health Equity Through Community and Academic Partnerships.

Public, Private & Faith-based Partnerships in Papua New Guinea How to provide innovative, needs-based programs to support HIV health care capacity building.

NIH Behavioral and Social Sciences Research: A Snapshot from OBSSR Deborah H. Olster, PhD Deputy Director Office of Behavioral and Social Sciences Research.

Introduction to the NIH Grants System

Director’s Report to the National Advisory Council on Drug Abuse Director’s Report to the National Advisory Council on Drug Abuse May 22, 2002 (Prepared.

Division of AIDS, Behavioral and Population Sciences Risk, Prevention and Health Behavior IRG August, 2014 Reorganization/Realignment of RPHB Addictive.

J. Nadine Gracia, MD, MSCE Deputy Assistant Secretary for Minority Health (Acting) Office of Minority Health U.S. Department of Health and Human Services.

African Americans and HIV: CA Office of AIDS Response Michelle Roland, MD Chief, Office of AIDS California Department of Public Health.

EVOLVING PUBLIC HEALTH AND HEALTH CARE LANDSCAPE AND OPPORTUNITIES FOR CANCER COMMUNICATION NCI Health Communication and Informatics Research Branch CPCRN.

Research Opportunities at the National Institutes of Health

HIV Prevention Trials Network Update Africa Regional Working Group 20 May 2003.

Cedars-Sinai Medical Center Capacity Building in Central and Eastern Europe: Research and Innovation Management Education and Training Innovation 2005.

Subcommittee on Children on Adolescents Provide input, as appropriate, to NIDA’s increasing programmatic efforts on child and adolescent issues Assist.

Science for Global Health: Fostering International Collaboration Norka Ruiz Bravo,PhD Special Advisor to the Director National Institutes of Health U.S.

06/17/09 Eunice Kennedy Shriver National Institute of Child Health and Human Development NICHD HIV Research Scientific Priorities Lynne Mofenson MD, Branch.

NACHGR MAY 20, 2013 PAMELA SANKAR, PHD UNIVERSITY OF PENNSYLVANIA GENOMICS AND SOCIETY WORKING GROUP: UPDATE AND REPORT.

Program Collaboration and Service Integration: An NCHHSTP Green paper Kevin Fenton, M.D., Ph.D., F.F.P.H. Director National Center for HIV/AIDS, Viral.

1 Promotoras, Peer Participant Providers and Community Outreach as Preconception in the Continuum of Perinatal HIV Transmission Armida Ayala, M.H.A., Ph.D.

Fogarty International Center: HIV Research Training Program: New Applications and Strategies Gene D. Morse, PharmD University at Buffalo AIDS International.

NIH U-01 Application Limited Competition: Women’s Interagency HIV Study (WIHS-V)

REPORT The National Advisory Council on Drug Abuse Work Group On NIDA’s Approach to Grant-Making May 2006 The National Institute on Drug Abuse.

FUTURE HIV RESEARCH EFFORTS PLANNED FOR THE CLINICAL TRIALS NETWORK James L. Sorensen, Ph.D. Susan Tross, Ph.D. Raul Mandler, M.D. University of California,

OFFICE OF AIDS RESEARCH DHHS/NIH/OAR NIH AIDS Research Priorities Jack Whitescarver, Ph.D. NIH Associate Director for AIDS Research and Director, OAR May.

Interamerican College of Physicians and Surgeons.

Director’s Report to the National Advisory Council on Drug Abuse Director’s Report to the National Advisory Council on Drug Abuse May 17, 2006.

Overview of NIDA Funding Opportunities and Grant Funding Tips Bethany Griffin Deeds, Ph.D., M.A. Deputy Chief, Epidemiology Research Branch Division of.

PANEL: Growing a Research Development Infrastructure from the Ground Up.

NIH Training Programs for International Early Stage Researchers International AIDS Society Conference Rome, Italy July 19, 2011 Robert W. Eisinger, Ph.D.

Elizabeth WellsDennis Daley School of Social WorkWestern Psychiatric Institute University of WashingtonUniversity of Pittsbu rgh Supported by Grants #

Public Health Issues Associated with Biological and Chemical Terrorism Scott Lillibridge, MD Director Bioterrorism Preparedness and Response Activity National.

Federally Qualified Health Centers (FQHCs): Addressing the Challenges of Health Care Reform Community Treatment Program (CTP) Caucus Clinical Trials Network.

University of Iowa Cancer Prevention and Control Research Network Sue Curry, Ph.D., Principal Investigator This presentation was supported by Cooperative.

Slide 1 Community Networks to Reduce Cancer Health Disparities Pre-Application Conference May 26, 2004 Bethesda, MD Kenneth C. Chu, PhD Chief, Disparities.

Other Intramural Training Opportunities at NCI Scientific DisciplinesProgram Population-based research, environmental & genetic determinants of cancer.

How Does Trauma contribute to Substance Abuse and HIV Infection Among Ethnic Women Gail E. Wyatt, Ph.D. Professor, UCLA Department of Psychiatry and Biobehavioral.

Report back from CWG Strategic Planning Strategic Planning Workshop February 2002 Janet Frohlich Steve Morin CWG International CWG US Co-Chair Co-chair.

REPORT From the Basic Science Review Work Group National Institute on Drug Abuse May 2006 National Institute on Drug Abuse Division of Basic Neuroscience.

Ryan White All Grantees Meeting Washington, DC November, 2012 Supporting National HIV/AIDS Strategies: the domestic experience and the AETCs.

Integration of HIV/AIDS, STD, TB and Viral Hepatitis New York State’s Experience Guthrie S. Birkhead, M.D., M.P.H. Director, AIDS Institute Director, Center.

NOAA Cooperative Institutes John Cortinas, Ph.D. OAR Cooperative Institute Program, Program Manager NOAA Cooperative Institute Committee, Chairperson.

Injection Drug Use and Hepatitis C What Can We Do About It? Wilson M. Compton, M.D., M.P.E. Deputy Director National Institute on Drug Abuse.

The Wisconsin Network for Health Research (WiNHR): Overview. An Infrastructure for Conducting Multi-Site Clinical Research across the State of Wisconsin.

The Importance of a Strategic Plan to Eliminate Health Disparities 2008 eHealth Conference June 9, 2008 Yvonne T. Maddox, PhD Deputy Director Eunice Kennedy.

HANC and Community Partners Overview November 20, 2007 Michael Petillo, Project Coordinator.

 Council Overview  Past Priorities and Recommendations  Current Priorities ◦ Promoting Equity in State Policies and Programs ◦ Adverse Birth Outcomes.

Robert H. Wiltrout Director, CCR Director’s Address.

NIDA’s Research Training Program Update for: National Advisory Council on Drug Abuse September 21, 2005.

Alcohol and AIDS: A New Decade Grantsmanship Workshop XIX International AIDS Conference Rome, Italy Kendall J. Bryant, Ph.D., NIAAA Alcohol and AIDS Research.

Update from the Division of Epidemiology, Services and Prevention Research Wilson M. Compton, M.D., M.P.E. Director, Division of Epidemiology, Services.

DIVISION OF NEUROSCIENCE AND BEHAVIORAL RESEARCH (DNBR) NATIONAL ADVISORY COUNCIL ON DRUG ABUSE FEBRUARY 14, 2001 NIDA NATIONAL INSTITUTE ON DRUG ABUSE.

David M. Murray, Ph.D. Associate Director for Prevention Director, Office of Disease Prevention Multilevel Intervention Research Methodology September.

Joel G. Breman, M.D., D.T.P.H Program Director, International Training and Research Program in Emerging Infectious Diseases Deputy Director, Division of.

Science for Global Health: Fostering International Research Collaboration James Herrington, PhD, MPH Director Division of International Relations Fogarty.

NIH HIV/AIDS Research Priorities

Funding Opportunities at the NIH-funded Centers for AIDS Research

Driving Future Success with Current Investments in HIV Research

Prevention Solutions for the Next Generation: Highlighting Adolescent Research in the NIH HIV/AIDS Clinical Trials Networks and the Adolescent Trials Network.

Aging with HIV: The NIH Research Agenda

Rachel Sturke, PhD Deputy Director and Senior Scientist

Division of AIDS Office of the Director Workforce Operations,

Behavioral and Social Science Research NIMH Division of AIDS Research

National Institutes of Health

Prevention Solutions for the Next Generation: Highlighting Adolescent Research in the NIH HIV/AIDS Clinical Trials Networks and the Adolescent Trials Network.

Presentation transcript:

Jacques Normand, Ph.D. Director, AIDS Research Program National Institute on Drug Abuse NIDA’s New HIV/AIDS Research Program

Objectives Update on NIDA’s New AIDS Research Program –CAMCODA –NIDA Council Recommendations –New AIDS Research Program –Structure –Research Priorities Brief Update on NIDA/NIH Collaborative Projects –Projects and Partners –New HPTN Network Drug Abuse Projects

CAMCODA Structure Director Medical Consequence Unit Human Development Unit Population- Based Intervention Unit Deputy Director Staff: 20 Professionals

CAMCODA116,035,000 DESPR 57,707,000 DTR&D 54,204,000 DNBR 29,615,000 CTN 12,052,000 NIDA AIDS FY03 AIDS Funding by Divisions

NIDA Advisory Council Workgroup on HIV/AIDS Report on Findings and Recommendations February, 2004

Structural & Procedural Recommendations Create new position of “Director, AIDS Research Program” reporting to NIDA’s Director Update policy/procedures to determine which projects qualify for AIDS funding Improve articulation of HIV/AIDS mission and planning process within & across Divisions/Centers Increase interaction across NIH, and with extramural community

NIDA’s AIDS Research Program Structure AIDS Research Program Mission: Plan, develop, coordinate and integrate research priorities within NIDA and externally. Staff: Jacques Normand Lynda Erinoff Helen Cesari AIDS Workgroup AIDS Coding Subgroup External Scientific AIDS Workgroup TBA

Division of Pharmacotherapies and Medical Consequences of Drug Abuse Jag Khalsa Ahmed Elkashef Jamie Biswas Division of Basic Neurosciences and Behavioral Research Diane Lawrence Cora Lee Wetherington Charles Sharp Yu Lin Minda Lynch NIDA’s AIDS Workgroup Membership

Division of Epidemiology, Services, and Prevention Research Elizabeth Lambert Division of Clinical Neurosciences, Development and Behavioral Treatment Lisa Onken Melissa Racioppo Nicolette Borek Ro Nemeth Center for Clinical Trials Network Mary Ellen Michel NIDA’s AIDS Workgroup Membership (Cont.)

Office of Science Policy & Communication Anna Staton International Program Steve Gust Intramural Research Program John Schmittner Office of Extramural Affairs Mark Green Office of Planning & Research Management Stacy Gardner NIDA’s AIDS Workgroup Membership (Cont.)

External Scientific AIDS Workgroup Proposed Membership (~ 8): Council Members Nominee per Division/Center Nominee from AIDS Program Proposed Task: Review NIDA’s AIDS Strategic Plan Review & make recommendations on new AIDS related procedural change (e.g., definition of AIDS and coding guidelines) Review NIDA’s priorities/initiatives

DPMC 52,046,000 DESPR 121,656,000 DCNDBT 46,336,000 DBNBR 29,374,000 CCTN 11,557,000 FY04 AIDS Funding by NIDA Divisions

NIDA’s FY04 Funding By OAR Research Areas of Emphasis 1.Natural History and Epidemiology $54,246,859 2.Etiology and Pathogenesis $29,028,598 3.Therapeutics $12,084,141 4.Vaccines $1,983,201 5.Behavioral and Social Science $186,583,465 6.Training, Infrastructure, and Capacity Building $6,860,742 7.Information Dissemination $1,594,994

Research Priority Recommendations Racial/ethnic disparities Emphasize case finding/treatment HAART interactions/adherence/resistance Newer HIV/IDU epidemics (Russia, China, India, Eastern Europe) Test drug T x for HIV prevention Emerging drugs (e.g., Meth/Viagra, NYC case/immunological & CNS impact ) Sexual risk behaviors (main exposure category) Adolescents (developmental/decision making, impulsivity) Role of drug abuse on transmission (drug type, partnership, context) Update programs with continuous review of epidemiologic and other findings

Current NIDA’s AIDS Program Tasks Explore new ways to attract new AIDS PIs Better integrate HIV/AIDS within and across NIDA Divisions/Centers and other NIH Institutes Working on Generating FY07 OAR Priorities (retooling priorities to establish strong presence in all Div/Ctr) Will be Generating NIDA FY06 AIDS Initiatives Developing Criteria for AIDS Grants Will be Appointing Members to Extramural Scientific AIDS Workgroup Will be Developing NIDA’s HIV/AIDS Strategic Plan

NIDA’s Collaborative Projects Network/Cohort Collaborating ICsNIDA’s Co-Fund Adolescent Trial Network NICHD, NIMH$1.0/20.0M Pediatric HIV AIDS Cohort Study NICHD, NIAID, NIMH $3.0/12.0M Centers For AIDS Research NIAID, NCI, NHLBI, & NIMH $4.6/33.3M Women Interagency HIV Study NIAID, NICHD, & NCI$0.5/18.5M HIV Prevention Trial Network NIAID,NIMH, NICHD, & FIC $4.4/70.0M

HPTN & New NIAID Network Current Projects Epidemiology HIV Prevention Drug Tx as HIV Prevention New Network Proposed protocols Community Scale-up; Stimulant pharmacotherapy as HIV prevention